<DOC>
	<DOCNO>NCT02050334</DOCNO>
	<brief_summary>The purpose study see CC100 , give mouth , safe tolerate increase dos . How long drug remain body also calculate .</brief_summary>
	<brief_title>CC100 : Safety Tolerability Single Doses</brief_title>
	<detailed_description>Approximately 18 healthy subject randomize receive mouth either 3 single increase dos CC100 1 dose placebo 2 increase dos CC100 . Dosing occur every 2 7 day study duration 5 15 day 1st dose . Subjects require stay Clinic approximately 24 hour follow dose . Subjects may choose optional lumbar puncture follow 3rd dose study drug .</detailed_description>
	<mesh_term>Caffeic acid</mesh_term>
	<criteria>Men must practice reliable method birth control study 2 week follow study . Women must nonfertile postmenopausal . Have serious unstable illness determine investigator . Have current history asthma , severe drug allergy pollen allergy . Have use medication ( except calcium supplement externally apply eye drop antibiotic ) within 30 day prior dose expect use medication study . Have serious infectious disease affect brain within precede 5 year ; know exist evidence serious infection . Have laboratory test value consider clinically significant determine investigator . Have ECG abnormality clinically significant . Have donate blood ( pint ) receive experimental drug within 30 day prior dose . Have history chronic alcohol drug abuse within past 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Safety</keyword>
	<keyword>Healthy Volunteer Safety Study</keyword>
</DOC>